Organic Chemistry TRIZ Cases

Specific solvents and acids convert tafamidis meglumine into stable crystalline Form 4 with at least 99.0% purity.

Near-infrared detection below silicon’s bandgap is addressed with an electron-accepting compound that improves detectivity and quantum efficiency.

A composite paint thinner uses a solvency promoter and balanced solvents to improve adhesion, drying time, gloss, and abrasion resistance.

Microchannel flow mixing controls exothermic chlorination of pyridine oxide solutions, reducing refrigerant use while improving yield and capacity.

Sequential Grignard, amine, iodine, and benzylation steps avoid protecting groups and chromatography for scalable pyridine production.

Spirocyclic cereblon binders support ubiquitination and target-protein degradation for abnormal cellular proliferation treatment.

Step-wise escalation of N-phenylsulfonyl benzamide Bcl-2 inhibitors targets blood cancers while reducing toxicity and tumor lysis syndrome risk.

UV-activated crosslinking attaches targeting molecules to cell-surface amino groups for rapid, nonviral cancer-cell therapy.

Polar groups improve protective-layer adhesion and chemical resistance in a 0.5–2.0 nm lubricant, helping suppress magnetic-head pickup.

Lipidic alkynylcarbinols target mycobacteria, including resistant strains, while reducing cytotoxicity toward mammalian cells.

Replacing hazardous halogenated solvents with non-halogenated media supports repeatable, scalable buprenorphine production.

Systematic substituent and linkage changes improve OLED efficiency, lower driving voltage, and extend service life.

An aromatic-amine-free initiator approach targets oxygen inhibition and incomplete curing while supporting rapid polymerization in dental restorations.

Deuterium-substituted host compounds combine complementary materials to lower driving voltage, increase luminous efficiency, and extend device lifetime.

Polyvalent ammonium salts catalyze thermosetting in silicon-containing underlayers to improve LWR and CDU while limiting residue defects.

High-nicotine oils are difficult to handle and incorporate; crystalline nicotine salts and co-crystals provide a manageable solid form.

An enantioselective ring opening of meso carbic anhydride builds a fused bicyclic ligand for inhibitors targeting drug-resistant HIV-1.

A direct MCPD-to-BCE reaction with metal alkoxides avoids prolonged multi-step processing and limits byproducts for commercial-scale production.

Tailored compounds improve hole and electron transport in OLED layers, addressing the efficiency and lifespan limits of conventional organic materials.

Specific carboxylic acid compounds increase correctly folded Z A1AT and secretion while sparing wild-type and Siiyama A1AT.

Small silicon pixels can lose sensitivity; a carbazole-based organic buffer helps extract charge and suppress dark current.

Organic amine crystallization and acid treatment turn Ti-MWW powder into a stronger catalyst for olefin epoxidation.

Liquid benzoxazine curatives address the high viscosity and slow gel times of solid resins while forming strongly cross-linked thermosets.

Dialkylaminoacrylate ester reacts with alkylhydrazine in direct cyclization, simplifying high-purity production and lowering raw-material costs.

5-aryl and heteroaryl-thiazole compounds inhibit PI4-kinase across pathogens and cancer cells, addressing inadequate broad-spectrum therapies.

High driving voltage in organic light-emitting devices is addressed with transport materials having GSP_slope ≥20 mV/nm.

Gold catalysis produces thieno[3,2-b]pyridine-5(4H)-one fluorophores with broad emission and improved resistance to blinking and photobleaching.

Limited STING therapies lack selective pathway control; benzimidazole dimers tune activation or inhibition of type I interferon.

Combining first and second host materials helps control energy barriers, balance charge, and extend phosphorescent element lifespan.

Specific heteroaryl groups tune energy levels and T1 values to lower driving voltage, improve luminous efficiency, and limit heat-driven crystallization.

Uncontrolled foam disrupts bioethanol processing; (poly)glycerol ether prevents new foam and rapidly collapses existing foam.

Mixed-stream recycle links ethane ODH and EO epoxidation while avoiding costly ethylene-ethane separation.

Chemical structure optimization targets selective POLQ inhibition while improving bioavailability and dosing suitability for HRD tumors.

Using a base and excess alkylating reagent, the process selectively substitutes four NH sites while avoiding phenol alkylation.

Controlled fraction removal produces a high-purity epoxy compound with low viscosity, reduced curing shrinkage, heat resistance, and transparency.

A p-type charge-generation layer combines formula (I) compounds with a covalent matrix to stabilize OLED operating voltage over device lifetime.

A full-hydrocarbon benzocyclobutene resin targets PCB dielectric loss while retaining heat resistance, moisture resistance, and mechanical strength.

Specific 6–28-carbon hydrocarbon groups help the compound resist thermal degradation and evaporation while preserving low-temperature fluidity.

13-cis retinamides degrade Mnk1/2, block eIF4E phosphorylation, and suppress breast and prostate cancer growth with minimal toxicity.

Multiple synthesis steps are replaced by halogenation and reduction in one vessel to produce haloether and vinyl ether more simply.

A three-step route uses sodium periodate, hydroxylamine hydrochloride, and formic acid to simplify roxadustat production at moderate temperatures.

Polyheterocyclic compounds bind mutant calreticulin’s N-glycan domain to disrupt MPL signaling and inhibit CALR-mutant cell growth.

A defined fluorene core used in injection, transport, and emitting layers helps raise OLED efficiency while extending device lifetime.

Optimized condensed cyclic compounds improve charge transport and recombination, helping OLEDs increase brightness and response speed.

Aconitic anhydride chloride directly modifies docetaxel without coupling reagents, reducing purification complexity while improving conjugate solubility.

Poorly soluble acid anhydride intermediates can limit yield and purity; direct amine condensation provides a cyclic imide route.

Fluorine compounds enable single-step fluorolactone production, reducing by-products and simplifying purification without hazardous materials.

ATP-pocket mutations and KRAS signaling limit EGFR inhibitors; these substituted compounds add aurora kinase A/B inhibition to address resistance.

A lower-mobility first layer limits lateral current loss, while a higher-mobility second layer maintains charge transport.

Specific deuterium-containing emitting-layer compounds help extend OLED lifetime while preserving the organic electroluminescence function.